Cargando…
Usability of Nasal Glucagon Device: Partially Randomized Caregiver and Third-Party User Experience Trial with Simulated Administration at a Japanese Site
INTRODUCTION: Glucagon is the only approved medicine for severe hypoglycemia available for caregivers of people with diabetes. Nasal glucagon (NG) was recently approved in the USA as a needle-free, ready-to-use alternative to injectable glucagon. This simulated user experience study in Japan compare...
Autores principales: | Aranishi, Toshihiko, Nagai, Yukiko, Takita, Yasushi, Zhang, Shuyu, Nishimura, Rimei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965568/ https://www.ncbi.nlm.nih.gov/pubmed/31686354 http://dx.doi.org/10.1007/s13300-019-00711-1 |
Ejemplares similares
-
Nasal glucagon as a viable alternative for treating insulin‐induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: A phase 3 randomized crossover study
por: Matsuhisa, Munehide, et al.
Publicado: (2020) -
Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57)
por: Ishigaki, Yasushi, et al.
Publicado: (2020) -
Pet dogs’ Behavioural Reaction to Their Caregiver’s Interactions with a Third Party: Join in or Interrupt?
por: Karl, Sabrina, et al.
Publicado: (2022) -
Third-party JavaScript
por: Vinegar, Ben, et al.
Publicado: (2013) -
Payment to a third party
Publicado: (1992)